Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes. Signatures of mutation and selection in the cancer genome. The Cancer Cell Line Encyclopedia …

2022年1月5日 · Cell information for MOLT-13. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.

molm-13细胞系建立于1995年，细胞自1例20岁的男性患者外周血分离获得。 该患者初诊为MDS-RAEB，之后进展为AML-M5，采集细胞时患者处于AML复发状态。

View drug sensitivity for MOLT-13 on CancerRxGene.org. Top-5 drugs with lowest z-score

6、24 小时后，人急性髓系白血病细胞MOLM-13恢复并贴满瓶壁，即可传代。 （贴壁细胞）将培养瓶里的培养基倒去，加 3-5ml（以能覆盖细胞生长面为准）PBS 或 Hanks’液洗涤后弃去。 加 0.5-1ml 0.25%含 EDTA 的胰酶消化，消化时间以具体细胞为准，一般 1-3 分钟，不超过 5 分钟。 可以放入37℃培养箱消化。 轻轻晃动瓶壁，见细胞脱落下来，加入 3-5ml 培养基终止消化。

molm-13 (人急性髓性白血病细胞)是从一名20岁的急性髓系白血病aml fab m5a患者在初始骨髓增生异常综合征（mds，难治性贫血伴母细胞过多，raeb）复发后的外周血中建立；

人急性T淋巴细胞白血病细胞MOLT-13取自2岁女性供体。该细胞源于DSMZ. 注释. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~80-120 hours (DSMZ). Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger). Omics: Deep exome analysis.

Cancer Cell Line: MOLT-13. Aliases: MOLT-13, CVCL_1422; Tissue: Blood; Cellosaurus: CVCL_1422; MOLT-13 is in CellMinerCDB, a searchable tool integrating cancer cell line pharmacogenomics data to link gene and drug activity signatures.

ATCELLBIO是一家专注于原代细胞定制及细胞系销售的生物科技公司，致力于为生命科学研究、药物开发和精准医疗提供高品质的细胞解决方案。

MOLT-13 cell line (T-cell leukaemia) was provided by DSMZ. Originally, the cells contained a heterozygous mutation, R273H, in TP53 ( Figure 4A). An equivalent ratio of wild-type to mutated...